FDA 483 - Pharmaron (Beijing) TSP Services Limited - August 01, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pharmaron (Beijing) TSP Services Limited in Beijing identified multiple deficiencies in Good Laboratory Practice (GLP) compliance. The firm failed to ensure accurate data recording, proper archiving of study materials, and adequate storage conditions for equipment and supplies. Additionally, issues were noted with adherence to standard operating procedures, animal care equipment sanitation, and the overall suitability of the facility for nonclinical laboratory studies.
ID · 6fee34e9-dfaa-4d75-b612-bd63ae0001f8